RPAM
Rhenman & Partners Asset Management’s INmune Bio INMB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Hold |
178,284
| – | – | 0.05% | 90 |
|
|
2025
Q1 | $1.39M | Hold |
178,284
| – | – | 0.16% | 74 |
|
|
2024
Q4 | $833K | Hold |
178,284
| – | – | 0.09% | 88 |
|
|
2024
Q3 | $961K | Hold |
178,284
| – | – | 0.08% | 95 |
|
|
2024
Q2 | $1.57M | Hold |
178,284
| – | – | 0.15% | 80 |
|
|
2024
Q1 | $2.09M | Hold |
178,284
| – | – | 0.2% | 75 |
|
|
2023
Q4 | $2.01M | Hold |
178,284
| – | – | 0.2% | 74 |
|
|
2023
Q3 | $1.22M | Hold |
178,284
| – | – | 0.13% | 80 |
|
|
2023
Q2 | $1.62M | Buy |
+178,284
| New | +$1.62M | 0.17% | 77 |
|